InterMune Director Tipped Pal On Drug OK, SEC Tells Jury
The U.S. Securities and Exchange Commission told a California federal jury Monday that phone records and the timing of trades would prove a former board member at medical company InterMune Inc....To view the full article, register now.
Already a subscriber? Click here to view full article